Science and Innovation Stories

Collaborating to Address Moderate to Severe Atopic Dermatitis

Amgen’s clinical trial program investigates a potential first-in-class mechanism of action for moderate to severe atopic dermatitis.

All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>

Load more